These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Ulrich D; Ulrich F; Piatkowski A; Pallua N Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795 [TBL] [Abstract][Full Text] [Related]
6. Combined Carpal Tunnel Release and Palmar Fasciectomy for Dupuytren's Contracture Does Not Increase the Risk for Complex Regional Pain Syndrome. Loewenstein SN; Duquette SP; Adkinson JM Plast Reconstr Surg; 2018 Nov; 142(5):1251-1257. PubMed ID: 30113442 [TBL] [Abstract][Full Text] [Related]
7. Is Dupuytren's disease caused by an imbalance between proliferation and cell death? Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921 [TBL] [Abstract][Full Text] [Related]
8. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous carpal tunnel release and Dupuytren's fasciectomy. Gonzalez F; Watson HK J Hand Surg Br; 1991 May; 16(2):175-8. PubMed ID: 2061659 [TBL] [Abstract][Full Text] [Related]
10. Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease. Dal Cin P; De Smet L; Sciot R; Van Damme B; Van den Berghe H Cancer Genet Cytogenet; 1999 Jan; 108(2):137-40. PubMed ID: 9973941 [TBL] [Abstract][Full Text] [Related]
11. The collagen changes of Dupuytren's contracture. Murrell GA; Francis MJ; Bromley L J Hand Surg Br; 1991 Aug; 16(3):263-6. PubMed ID: 1960490 [TBL] [Abstract][Full Text] [Related]
12. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301 [TBL] [Abstract][Full Text] [Related]
13. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. Tomasek J; Rayan GM J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925 [TBL] [Abstract][Full Text] [Related]
14. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts. Rayan GM; Tomasek JJ Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248 [TBL] [Abstract][Full Text] [Related]
15. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture. Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715 [TBL] [Abstract][Full Text] [Related]
16. Treatment considerations in carpal tunnel syndrome with coexistent Dupuytren's disease. Nissenbaum M; Kleinert HE J Hand Surg Am; 1980 Nov; 5(6):544-7. PubMed ID: 7430596 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Ulrich D; Hrynyschyn K; Pallua N Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511 [TBL] [Abstract][Full Text] [Related]
18. Free radicals and Dupuytren's contracture. Murrell GA; Francis MJ; Bromley L Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1373-5. PubMed ID: 2825907 [TBL] [Abstract][Full Text] [Related]
19. Association of advanced glycation end products in Dupuytren disease. Takase F; Mifune Y; Inui A; Ueda Y; Kataoka T; Kokubu T; Kuroda R J Orthop Surg Res; 2018 Jun; 13(1):143. PubMed ID: 29880057 [TBL] [Abstract][Full Text] [Related]